PER 0.00% 8.4¢ percheron therapeutics limited

Ann: ANP Submits US Orphan Drug application for ATL1102 in DMD, page-60

  1. 694 Posts.
    lightbulb Created with Sketch. 196
    Have to agree with you on this point Andy.

    I have positions in MSB and IMU. Their management teams are excellent and their CEO's are superb with both experts at the science behind their products. Both are also extremely articulate. MSB's CEO was brilliant in a recent ODAC meeting to get a 9-1 approval for Remestemcell-L
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
0.000(0.00%)
Mkt cap ! $75.73M
Open High Low Value Volume
8.4¢ 8.5¢ 8.4¢ $31.98K 379.3K

Buyers (Bids)

No. Vol. Price($)
2 262571 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 119843 1
View Market Depth
Last trade - 14.51pm 19/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.